Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T Cell Lymphomas; Evidence of Graft-Versus-T Cell Lymphoma Effect

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 4, 2008, Pages 480-483

  Hamadani, Mehdi ^a   Awan, Farrukh T ^a   Elder, Patrick ^a   Lin, Thomas S ^a   Porcu, Peirluigi ^a   Blum, Kristie A ^a   Devine, Steven M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; ENGRAFTMENT; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS LYMPHOMA EFFECT; HUMAN; LARGE CELL LYMPHOMA; LETTER; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; MYCOSIS; MYELOABLATIVE CONDITIONING; NEUTROPHIL; REDUCED INTENSITY CONDITIONING; SEPSIS; SIBLING; SUDDEN DEATH; T CELL LYMPHOMA; THROMBOCYTE;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 40649087167     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.01.002     Document Type: Letter

References (9)

1. Feyler S., Prince H.M., Pearce R., et al. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 40 5 (2007) 443-450
2. Gisselbrecht C., Gaulard P., Lepage E., et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 92 1 (1998) 76-82
3. Vose J.M., Peterson C., Bierman P.J., et al. Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood 76 2 (1990) 424-431
4. Rodriguez J., Munsell M., Yazji S., et al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 19 17 (2001) 3766-3770
5. Blystad A.K., Enblad G., Kvaløy S., et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 27 7 (2001) 711-716
6. Kahl C., Leithäuser M., Wolff D., et al. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Ann Hematol 81 11 (2002) 646-650
7. Feyler S., Prince H.M., Pearce R., et al. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 40 5 (2007) 443-450
8. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17 12 (1999) 3835-3849
9. Corradini P., Dodero A., Zallio F., et al. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 22 11 (2004) 2172-2176